Clinical Trials Browser

Unknown × Neoplasm Metastasis × Dermatologic × Clear all

NCT04137900 2024-02-05

Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies

Phase 1 Unknown

DermatologicLymphoidThoracic

Carcinoma, Non-Small-Cell Lung, Lymphoma, Melanoma, Neoplasm Metastasis

NCT06236360 2024-02-01

MINI-MD

Phase NA Unknown

Melanoma, Neoplasm Metastasis

NCT04720768 2024-01-05

CELEBRATE

Phase 1/2 Unknown

Melanoma, Neoplasm Metastasis

NCT05094804 2023-11-02

A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents

Phase 1/2 Unknown

DermatologicHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Leiomyosarcoma, Liposarcoma, Melanoma, Neoplasm Metastasis, Neoplasms

NCT05845632 2023-08-16

Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma

DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Squamous Cell, Neoplasm Metastasis, Recurrence, Skin Neoplasms

NCT05077280 2022-12-06

A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma

Phase 2 Unknown

Uveal Melanoma, Neoplasm Metastasis

NCT00986661 2022-11-02

A Study to Assess PV-10 Chemoablation of Cancer of the Liver

Phase 1 Unknown

BreastDermatologicEndocrineGastrointestinalThoracic

Uveal Melanoma, Breast Neoplasms, Carcinoid Tumor, Colonic Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Pancreatic Neoplasms, Colorectal Neoplasms

NCT02076646 2022-04-14

A Phase I/II Dose Escalation Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Dacarbazine for Patients With Metastatic Melanoma

Phase 1/2 Unknown

Melanoma, Neoplasm Metastasis

NCT03715985 2022-01-11

NeoPepVac

Phase 1/2 Unknown

Melanoma, Neoplasm Metastasis

NCT05047276 2021-09-17

PULSE-UM

Phase 1/2 Unknown

Uveal Melanoma, Neoplasm Metastasis

NCT03896958 2020-12-04

PIONEER

BreastCNSDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Adenocarcinoma of Lung, Adrenal Gland Neoplasms, Anus Neoplasms, Bile Duct Neoplasms, Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Glioblastoma, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Kidney Neoplasms, Laryngeal Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Neoplasms, Unknown Primary, Neurologic Manifestations, Oligodendroglioma, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Sarcoma, Skin Neoplasms, Stomach Neoplasms, Testicular Neoplasms, Uterine Neoplasms, Vulvar Neoplasms, Cholangiocarcinoma, Small Cell Lung Carcinoma, Thyroid Carcinoma, Anaplastic

NCT03013101 2020-09-30

Safety and Efficacy of Recombinant Humanized Anti-PD-1 mAb for Patients With Locally Advanced or Metastatic Melanoma

Phase 2 Unknown

Melanoma, Neoplasm Metastasis

NCT04072900 2020-04-28

A Personalized NeoAntigen Cancer Vaccine Combined With Anti-PD-1 in Melanoma

Phase 1 Unknown

Melanoma, Neoplasm Metastasis

NCT02452294 2017-05-03

BUMPER

Phase 2 Unknown

Melanoma, Neoplasm Metastasis

NCT01565837 2016-02-01

SART

Phase 2 Unknown

Melanoma, Neoplastic Cells, Circulating, Neoplasm Metastasis

NCT00477906 2015-12-03

M-Vax + Low Dose Interleukin-2 Versus Placebo Vaccine in Metastatic Melanoma in Patients With Stage IV Melanoma

Phase 3 Unknown

Melanoma, Neoplasm Metastasis

NCT01960829 2015-05-01

Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety Study

Phase 2 Unknown

Melanoma, Neoplasm Metastasis

NCT02408835 2015-04-06

Negative Pressure Wound Therapy in Groin Dissection

Phase NA Unknown

Lymphatic Metastasis, Neoplasm Metastasis, Skin Neoplasms

NCT00553683 2014-01-14

Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer

Phase 1/2 Unknown

BreastDermatologicGastrointestinalGynecologic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Colonic Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT00039234 2013-12-18

Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Stage IV Melanoma Metastatic to the Liver

Phase 3 Unknown

Melanoma, Neoplasm Metastasis

NCT00779714 2008-10-24

ChemoSensMM

Phase 3 Unknown

Melanoma, Neoplasm Metastasis

NCT00116363 2008-04-01

Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma

Phase 2 Unknown

Adenoviridae Infections, Melanoma, Neoplasm Metastasis

NCT00406900 2006-12-06

Melanoma Inhibitory Activity (MIA): A Serological Marker for Metastatic Uveal Melanoma

Uveal Melanoma, Melanoma, Neoplasm Metastasis

NCT00226473 2006-06-21

Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant Melanoma

Phase 4 Unknown

Melanoma, Neoplasm Metastasis